ARX
AROA BIOSURGERY ORDINARYAroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. The company also develops products for abdominal wall reconstruction, hernia repair, and breast reconstruction in North America and Europe. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.
ARX
ARX
AROA BIOSURGERY ORDINARY
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 0.00% | — |
| 10 July | 0.00% | — |
| 9 July | 0.00% | — |
| 8 July | 0.00% | — |
| 7 July | 0.00% | — |
| 6 July | 0.00% | — |
| 3 July | 0.00% | — |
| 2 July | 0.00% | — |
| 1 July | 0.00% | — |
Aroa Biosurgery (ARX) Short Interest Summary
Aroa Biosurgery (ARX) currently has 0.00% of its shares sold short (1 thousand shares, worth approximately $1K), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes ARX the #695 most shorted stock on the ASX most shorted list. Short interest in ARX is up 0.00% over the past week and down 0.00% over the past month. ARX is part of the Health Care sector on the ASX.
Recent ARX Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 0.00% | 0.0M | $0.58 |
| 10 July 2026 | 0.00% | 0.0M | $0.59 |
| 9 July 2026 | 0.00% | 0.0M | $0.58 |
| 8 July 2026 | 0.00% | 0.0M | $0.60 |
| 7 July 2026 | 0.00% | 0.0M | $0.57 |
| 6 July 2026 | 0.00% | 0.0M | $0.56 |
| 3 July 2026 | 0.00% | 0.0M | $0.57 |
| 2 July 2026 | 0.00% | 0.0M | $0.60 |
| 1 July 2026 | 0.00% | 0.0M | $0.59 |
| 30 June 2026 | 0.00% | 0.0M | $0.60 |
ARX Short Selling — Frequently Asked Questions
What is Aroa Biosurgery (ARX)'s current short interest?
Aroa Biosurgery (ARX) currently has a short interest of 0.00% of total shares outstanding. This means 0.00% of ARX's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is ARX heavily shorted on the ASX?
ARX has a relatively low short interest of 0.00%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for ARX investors?
Short interest in ARX shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.00%, ARX's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this ARX short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for ARX.